Wayfinding Financial, LLC Gilead Sciences, Inc. Transaction History

Wayfinding Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	SELL	$73.27 - $83.09 $42,350 - $48,026	-578 Reduced 17.19%	2,784 $225,000
Q3 2023 Nov 02, 2023	BUY	$73.94 - $80.67 $16,192 - $17,666	219 Added 6.97%	3,362 $251,000
Q2 2023 Jul 31, 2023	SELL	$76.01 - $86.7 $9,197 - $10,490	-121 Reduced 3.71%	3,143 $242,000
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $252,339 - $287,493	3,264 New	3,264 $270,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Wayfinding Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Wayfinding Financial, LLC with notifications on news.